Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...

As AI transforms education, we must redefine intelligence beyond biological limits and embrace cognitive functions across ...

Through the collaboration, Applied StemCell is providing Syntax Bio with iPSC lines, including its GMP-compatible hypoimmune iPSC platform, which combines immune-evasion genome engineering with ...

Before he sends a dozen runners from Santa Anita to Del Mar, trainer Librado Barocio is trying to pare down his stable. Barocio trainees are up for sale. Veteran sprinter One Smokin Dude is a ...

How speech therapy and reading intervention can transform support for students with language-based learning differences.

The path from block-based programming to vibe coding represents a shift from mastering the mechanics of implementation to ...

Eleusinia Retreat, a medically supervised psilocybin and DMT retreat program based in Valle de Bravo, Mexico, today announced ...

Neko Health, the health technology company redefining how people understand and act on their health, today announced its most significant advancements so far to the Neko Health Scan: body composition ...

Sovereign-by-design SAP delivery gains urgency in Germany as enterprises add AI-supported automation to control risk, ISG ...